The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2022 | What to look forward to at ASCO GI 2022
Scott Kopetz, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, talks on what he is most looking forward to at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022. Dr. Kopetz is excited about discussion on updates in clinical trials and data on circulating tumor cells (CTCs) and how CTCs can be utilized in colorectal cancer (CRC) as well as other tumor types. This interview took place at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.
